Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The HOXC13 gene affects different hair proteins in cashmere goats in varied ways and is controlled by a feedback loop and other factors.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

The document is a detailed guide on skin conditions and treatments for dermatologists.

Forensic hair analysis for drugs is now more reliable and accurate.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Zeb2 is crucial for nerve repair by controlling Schwann cell function.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Blocking TRPV3 may help treat itch in dry skin conditions.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Testosterone replacement is recommended for men with low testosterone levels and symptoms of hypogonadism.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Nano-phytopharmaceuticals show promise but need more research for safe, effective use in treating certain disorders.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Hair melanocytes help the skin respond to stress and regulate hair pigmentation.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Finasteride may lower cholesterol and slow heart disease progression.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Neurotoxins can affect neurotransmitter release and have potential in treating muscle, pain, and cancer conditions, but more research is needed on how they work.